Corporate News Report – Market Performance Update
- Company: Longeveron Inc. (Ticker: LGVN)
- Current Trading Session: 24‑hour period ending 11:10 AM Central Europe, Friday, 23 Oct 2026
- Price Movement: Down 4.67 %
- Current Price: USD 1.59 per share
- Shares Outstanding: 3 million
- Market Capitalisation: USD 4.6 million
- Volume (last 24 h): USD 117.4 k worth of shares traded
- Year‑to‑Date Performance: Down 47.43 % since the end of September 2026
- 200‑Day Simple Moving Average: USD 6.78
- 52‑Week High: USD 12.30 on 04 July 2026
- 52‑Week Low: USD 1.31 on 19 Oct 2026
Comparative Performance of Related Stocks (last 24 h)
| Ticker | % Change | Current Price (USD) | Market Capitalisation (USD) |
|---|---|---|---|
| VNRX | 0 % | 0.17 | 5 million |
| WKSP | -5.92 % | 0.31 | 5.1 million |
| RVLWF | 0 % | 0.04 | 5.4 million |
| SNOA | +0.88 % | 1.15 | 5.5 million |
| CDIO | +2.91 % | 1.70 | 5.2 million |
Company Overview
Longeveron Inc. is a clinical‑stage biotechnology company headquartered in Miami, Florida, USA. The company focuses on developing cellular therapies for aging‑related and life‑threatening conditions. Longeveron operates on a global scale and provides its services to customers worldwide. Further information on the company’s activities and offerings can be found on its website, www.longeveron.com , and its stock is traded on the Nasdaq exchange.
